Cold Spring Harbor Laboratory
12
1
5
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
14%
1 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Molecular Studies and Clinical Correlations in Human Prostatic Disease
Role: collaborator
Pancreatic Adenocarcinoma Signature Stratification for Treatment
Role: collaborator
Cough Capture as a Portal Into the Lung
Role: collaborator
Genomic Structural Variation in Cancer Susceptibility
Role: collaborator
Clinical Significance of Germline BRCA Mutations
Role: collaborator
Famotidine Outpatient COVID-19 Treatment Study
Role: collaborator
Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM)
Role: collaborator
Famotidine vs Placebo for the Treatment of Non-Hospitalized Adults With COVID-19
Role: collaborator
Pancreatic Intraepithelial Neoplasia (PanIN) and the Association With Recurrence of Pancreatic Adenocarcinoma
Role: collaborator
Dornase Alfa Administered to Patients With COVID-19 (DACOVID)
Role: collaborator
Effect of OMM on Anandamide Levels in Saliva
Role: collaborator
Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection
Role: collaborator
All 12 trials loaded